Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10451 | 1062 | 26.0 | 58% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
156 | 3 | MYCOSES//MYCOLOGY//CANDIDA ALBICANS | 62026 |
55 | 2 | CANDIDA ALBICANS//CANDIDA//ASPERGILLOSIS | 29629 |
10451 | 1 | VULVOVAGINAL CANDIDIASIS//RECURRENT VULVOVAGINAL CANDIDIASIS//VAGINAL CANDIDIASIS | 1062 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | VULVOVAGINAL CANDIDIASIS | authKW | 1394906 | 8% | 56% | 87 |
2 | RECURRENT VULVOVAGINAL CANDIDIASIS | authKW | 534204 | 2% | 77% | 24 |
3 | VAGINAL CANDIDIASIS | authKW | 467288 | 3% | 51% | 32 |
4 | VAGINAL CANDIDOSIS | authKW | 320003 | 2% | 70% | 16 |
5 | VAGINITIS | authKW | 271522 | 4% | 21% | 46 |
6 | VULVOVAGINAL CANDIDOSIS | authKW | 256136 | 1% | 64% | 14 |
7 | CANDIDIASIS VULVOVAGINAL | authKW | 205360 | 1% | 71% | 10 |
8 | RECURRENT VULVOVAGINAL CANDIDOSIS | authKW | 201258 | 1% | 100% | 7 |
9 | RECURRENT VAGINAL CANDIDIASIS | authKW | 176099 | 1% | 88% | 7 |
10 | CANDIDA VAGINITIS | authKW | 117395 | 1% | 58% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Mycology | 9271 | 12% | 0% | 128 |
2 | Obstetrics & Gynecology | 8481 | 27% | 0% | 290 |
3 | Infectious Diseases | 3675 | 18% | 0% | 191 |
4 | Dermatology | 1425 | 9% | 0% | 98 |
5 | Microbiology | 950 | 14% | 0% | 145 |
6 | Immunology | 700 | 14% | 0% | 147 |
7 | Medicine, General & Internal | 482 | 11% | 0% | 120 |
8 | Primary Health Care | 459 | 2% | 0% | 23 |
9 | Pharmacology & Pharmacy | 346 | 13% | 0% | 137 |
10 | Reproductive Biology | 226 | 3% | 0% | 34 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CLIN GENITOURINARY INFECT | 64689 | 0% | 75% | 3 |
2 | GYNAECOL ASSESSMENT CLIN | 64689 | 0% | 75% | 3 |
3 | KPIG 3 | 38334 | 0% | 67% | 2 |
4 | NAT COMPLEMENTARY MED UNIT | 38334 | 0% | 67% | 2 |
5 | ZAKLAD ZAKAZEN TER II PLODU | 38334 | 0% | 67% | 2 |
6 | MICROBIOL IMMUNOL PARASITOL | 38092 | 4% | 3% | 44 |
7 | ADV CARE PROD | 28751 | 0% | 100% | 1 |
8 | ALZAHRAH HOSP | 28751 | 0% | 100% | 1 |
9 | CCEU RD MED AFFAIRS | 28751 | 0% | 100% | 1 |
10 | CENT S MED BASIC SCI | 28751 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MYCOSES | 24022 | 5% | 2% | 50 |
2 | GENITOURINARY MEDICINE | 12806 | 2% | 2% | 22 |
3 | MYKOSEN | 8989 | 1% | 2% | 13 |
4 | BRITISH JOURNAL OF VENEREAL DISEASES | 6959 | 1% | 2% | 10 |
5 | JOURNAL DE MYCOLOGIE MEDICALE | 5534 | 1% | 1% | 13 |
6 | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 5448 | 6% | 0% | 62 |
7 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 4668 | 3% | 1% | 28 |
8 | MEDICAL MYCOLOGY | 4390 | 2% | 1% | 18 |
9 | JOURNAL OF REPRODUCTIVE MEDICINE | 4124 | 3% | 0% | 30 |
10 | MYCOPATHOLOGIA | 3514 | 2% | 1% | 21 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOBEL, JD , (2007) VULVOVAGINAL CANDIDOSIS.LANCET. VOL. 369. ISSUE 9577. P. 1961 -1971 | 70 | 61% | 313 |
2 | MENDLING, W , (2015) GUIDELINE: VULVOVAGINAL CANDIDOSIS (AWMF 015/072), S2K (EXCLUDING CHRONIC MUCOCUTANEOUS CANDIDOSIS).MYCOSES. VOL. 58. ISSUE . P. 1 -15 | 72 | 62% | 10 |
3 | MENDLING, W , BRASCH, J , (2012) GUIDELINE VULVOVAGINAL CANDIDOSIS (2010) OF THE GERMAN SOCIETY FOR GYNECOLOGY AND OBSTETRICS, THE WORKING GROUP FOR INFECTIONS AND INFECTIMMUNOLOGY IN GYNECOLOGY AND OBSTETRICS, THE GERMAN SOCIETY OF DERMATOLOGY, THE BOARD OF GERMAN DERMATOLOGISTS AND THE GERMAN SPEAKING MYCOLOGICAL SOCIETY.MYCOSES. VOL. 55. ISSUE . P. 1-13 | 64 | 69% | 22 |
4 | RATHOD, SD , BUFFLER, PA , (2014) HIGHLY-CITED ESTIMATES OF THE CUMULATIVE INCIDENCE AND RECURRENCE OF VULVOVAGINAL CANDIDIASIS ARE INADEQUATELY DOCUMENTED.BMC WOMENS HEALTH. VOL. 14. ISSUE . P. - | 47 | 85% | 6 |
5 | NYIRJESY, P , SOBEL, JD , (2013) GENITAL MYCOTIC INFECTIONS IN PATIENTS WITH DIABETES.POSTGRADUATE MEDICINE. VOL. 125. ISSUE 3. P. - | 61 | 62% | 15 |
6 | DONDERS, GGG , BELLEN, G , MENDLING, W , (2010) MANAGEMENT OF RECURRENT VULVO-VAGINAL CANDIDOSIS AS A CHRONIC ILLNESS.GYNECOLOGIC AND OBSTETRIC INVESTIGATION. VOL. 70. ISSUE 4. P. 306-321 | 59 | 69% | 20 |
7 | GONCALVES, B , FERREIRA, C , ALVES, CT , HENRIQUES, M , AZEREDO, J , SILVA, S , (2016) VULVOVAGINAL CANDIDIASIS: EPIDEMIOLOGY, MICROBIOLOGY AND RISK FACTORS.CRITICAL REVIEWS IN MICROBIOLOGY. VOL. 42. ISSUE 6. P. 905 -927 | 96 | 38% | 0 |
8 | FIDEL, PL , (2007) HISTORY AND UPDATE ON HOST DEFENSE AGAINST VAGINAL CANDIDIASIS.AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY. VOL. 57. ISSUE 1. P. 2 -12 | 49 | 75% | 64 |
9 | SOBEL, JD , (2016) RECURRENT VULVOVAGINAL CANDIDIASIS.AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY. VOL. 214. ISSUE 1. P. 15 -21 | 33 | 65% | 9 |
10 | AMOURI, I , ABBES, S , SELLAMI, H , MAKNI, F , SELLAMI, A , AYADI, A , (2010) VULVOVAGINAL CANDIDIASIS: A REVIEW.JOURNAL DE MYCOLOGIE MEDICALE. VOL. 20. ISSUE 2. P. 108 -115 | 41 | 77% | 7 |
Classes with closest relation at Level 1 |